Sotera Health Company SHC

18.34 (0.11) (0.60%) as of 25 Sep
Market cap
$5.3B
P/E
32.1×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more quarters

311.31 303.44 280.05 321.38
Revenue Growth
9.05% 4.56% 10.03% 9.18%
Cost of Revenue
133.75 137.52 132.98 143.41
Gross Profit
177.56 165.92 147.07 177.96
SG&A Expenses
63.29 57.51 68.21 68.16
Operating Income
111.18 105.38 75.83 106.79
Non-operating Interest Expenses
39.15 35.05 34.75 34.41
Non-operating Income/Expense
(38.24) (34.89) (33.21) (28.74)
EBT
72.94 70.50 42.61 78.05
Income Tax Provision
24.54 35.65 16.02 24.41
Income after Tax
48.40 34.85 26.59 53.64
Net Income Common
48.40 34.84 26.59 53.64
EPS (Basic)
0.17 0.12 0.09 0.19
EPS (Diluted)
0.17 0.12 0.09 0.19
Shares (Basic, Weighted)
284.07 283.96 284.89 285.77
Shares (Diluted, Weighted)
286.75 286.42 287.62 288.15
Gross Margin
57.04% 54.68% 52.52% 55.38%
EBIT Margin
35.71% 34.73% 27.08% 33.23%
EBT margin
23.43% 23.23% 15.22% 24.29%
Net Profit Margin
15.55% 11.48% 9.49% 16.69%
EBITDA
140.84 139.39 108.11 141.82
EBIT
111.18 105.38 75.83 106.79
Income from Continuous Operations
48.40 34.85 26.59 53.64
Consolidated Net Income/Loss
48.40 34.85 26.59 53.64
EPS (Basic, from Continuous Ops)
0.17 0.12 0.09 0.19
EPS (Diluted, from Cont. Ops)
0.17 0.12 0.09 0.19
EPS (Basic, Consolidated)
0.17 0.12 0.09 0.19
EPS (Diluted, Consolidated)
0.17 0.12 0.09 0.19
Shares (Diluted, Average)
286.75 287.55 287.62 288.15
EBITDA Margin
45.24% 45.94% 38.60% 44.13%
Operating Cash Flow Margin
22.86% 33.98% 10.51% 27.54%

Fold the line items

In millions of $ except per-share values · columns are period end dates